President, CEO & Chairman of the Board, Zimmer Biomet
Search every verified Ivan Tornos interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Ivan Tornos, President, CEO and Chairman of Zimmer Biomet, has described the company as undergoing a transformation from a legacy product company to a technology company. In public appearances throughout 2025, Tornos stated that the company is disrupting its strategy, operations, and culture while keeping its purpose of alleviating pain unchanged. He highlighted the company’s focus on autonomous robotics, smart implants, data algorithms, and remote surgery capabilities, including a partnership with Monogram Technologies for fully autonomous procedures and a collaboration with Microsoft for mixed-reality guided surgeries. Tornos also noted that Zimmer Biomet plans to launch 50 new products over 36 months and that 40 to 60 percent of orthopedic cases are expected to shift to ambulatory surgical centers. Tornos has emphasized the importance of patient awareness, citing that 600 million people suffer from arthritis but fewer than 5 percent seek treatment. He discussed a partnership with Arnold Schwarzenegger, who serves as Chief Wellness Officer, to educate patients about
“Your reimbursement every day goes down. For the last 23, 25 years, you're making less money.”
“Monogram Technologies will be the first technology company in orthopedic robotics that enables fully autonomous procedures. I'm not here to tell you that Zimmer Biomet wants to eliminate the surgeon — I'm here to tell you we will provide optionality, from the surgeon fully in charge to, in some rural areas like India,...”
“So we every six seconds we replace somebody's body part... we do foot ankle replacements, shoulder replacements, hip replacements, knee replacements — we put parts inside of your brain and again we've been doing this for 100 years.”
“Zimmer Biomet just bought the first fully autonomous robot in the world that can do the surgery — 100% the robot itself — and can do robotics remotely.”
Ivan Tornos always brings a straightforward, clearly communicated, and passionate focus as a leader. Ivan shares the Zimmer ...
Recorded during our annual economic forum, Latin America, the United States and Spain in the Global Economy, held in New ...
In this inspiring discussion, Ivan Tornos, CEO of Zimmer Biomet, shares his vision for the future of MedTech. Tornos believes we ...I'm here with Ivan Tornos, the CEO of Zimmer Biomet. Ivan, thanks for joining us. You have such a passion for MedTech, so I think ...
Ivan Tornos, Zimmer Biomet CEO, joins 'Closing Bell Overtime' from the CNBC CEO Council Summit to talk navigating a changing ...
► Subscribe to Our Channel Here / mullingsgroup --------------- LinkedIn: / the-m. . Website: http://mullingsgroup.com/ #TheMullingsGroup #TMG
In this episode of the DeviceTalks Weekly podcast, Host Tom Salemi interviews Alan Lotvin, MD, the CEO and co-founder of Sequel Med Tech, a small company promoting another BIG idea from prolific inventor Dean Kamen. Lotvin, who was formerly a senior executive at CVS/Caremark and PBMs, explains how Twiist, the automated insulin delivery system, could be a game-changer for people with diabetes. Before the interview, we’ll hear from Ivan Tornos, the CEO and president of Zimmer Biomet. Tornos, who is the opening keynote interview guest at DeviceTalks Boston on April 30 at the Boston Convention &…
The New York Hall of Science in Corona, Queens is a nationally recognized museum, fostering passion for learning, critical ...
In this engaging interview, Iván Tornos, a seasoned global professional and CEO, shares invaluable insights from his extensive career. Discover the profound impact of international experiences on professional growth and how living in different countries can enhance critical thinking and problem-solving abilities. Iván emphasizes the importance of lifelong learning, revealing his disciplined approach to continuous education, including dedicating weekly hours to networking, reading, and conversations with mentors. He discusses the evolution of his management style, transitioning from a focus on…
This week, Dr. Scott Sigman is joined by Ivan Tornos, CEO of Zimmer Biomet. Here, they discuss the culture he's developed at ...
► Subscribe to Our Channel Here / mullingsgroup --------------- LinkedIn: / the-m. . Website: http://mullingsgroup.com/ #TheMullingsGroup #TMG
Sign in to search the full transcript archive, filter by topic, and access every quote from Ivan Tornos.